$349.23 0.00 (0.00%)

Waters Corp (WAT)

Waters Corporation (WAT) is a global provider of analytical technologies, primarily serving the life sciences, pharmaceutical, and biopharmaceutical markets. Founded in 1958, the company specializes in laboratory instruments, software, and consumables used in scientific research, quality testing, and drug development. Waters is known for its chromatography and mass spectrometry systems, which enable precise and accurate analysis of complex samples.

🚫 Waters Corp does not pay dividends

Company News

Chromatography Technologies Powering the Future of Biopharmaceuticals
GlobeNewswire Inc. • Bcc Research • September 23, 2025

The global chromatography market in pharmaceuticals and biotechnology is projected to grow from $13.3 billion in 2025 to $19.8 billion by 2030, with an 8.4% CAGR, driven by rising biopharmaceutical innovations, regulatory standards, and demand for generics and biosimilars.

Becton's Biosciences And Diagnostics Arm Slated To Join Waters In $17.5 Billion Merger
Benzinga • Vandana Singh • July 14, 2025

Becton Dickinson will combine its Biosciences & Diagnostic Solutions business with Waters Corporation in a $17.5 billion tax-efficient Reverse Morris Trust transaction, expected to close by Q1 2026.

Compared to Estimates, Waters (WAT) Q2 Earnings: A Look at Key Metrics
Zacks Investment Research • N/A • July 31, 2024

Waters (WAT) reported a 4.3% decline in revenue and a 6.1% decrease in EPS for Q2 2024 compared to the same period last year. The company's performance was mixed across its divisions, with the Water division and TA division seeing declines, while the service business saw growth.

Among the S&P 500, these 20 companies have made the best use of investors’ money
MarketWatch • MarketWatch • October 25, 2023

High returns on invested capital can be useful for narrowing down a list of stocks for investment.

Earnings Growth Improves as Investors Ready Themselves for Retailers
Investing.com • Christine Short • February 13, 2023

Related Companies